Clinical Trial Update: A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab [Phase 3]

View source ↗

Summary

A Phase 3 trial update indicates AstraZeneca is initiating a study to evaluate tezepelumab for symptoms in adults with chronic rhinosinusitis with nasal polyps.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: RECRUITING